IRIS
DE FABRITIIS, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.412
AS - Asia 5.194
EU - Europa 3.741
SA - Sud America 841
Continente sconosciuto - Info sul continente non disponibili 518
AF - Africa 73
OC - Oceania 12
Totale 47.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.155
SG - Singapore 2.540
CN - Cina 836
IT - Italia 712
RU - Federazione Russa 694
BR - Brasile 672
HK - Hong Kong 616
DE - Germania 599
VN - Vietnam 445
UA - Ucraina 436
IE - Irlanda 380
GB - Regno Unito 248
BD - Bangladesh 188
FR - Francia 187
JP - Giappone 177
FI - Finlandia 120
CA - Canada 117
SE - Svezia 106
KR - Corea 95
IN - India 67
MX - Messico 58
NL - Olanda 52
AR - Argentina 50
PL - Polonia 48
AT - Austria 38
TR - Turchia 31
IQ - Iraq 28
EC - Ecuador 27
ID - Indonesia 27
ES - Italia 25
ZA - Sudafrica 24
CO - Colombia 20
BE - Belgio 18
UZ - Uzbekistan 18
PY - Paraguay 17
VE - Venezuela 17
PK - Pakistan 16
CL - Cile 15
JM - Giamaica 15
CR - Costa Rica 14
PH - Filippine 14
NI - Nicaragua 13
CZ - Repubblica Ceca 12
RO - Romania 12
AU - Australia 10
KE - Kenya 10
GR - Grecia 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IL - Israele 8
IR - Iran 8
LT - Lituania 8
MA - Marocco 8
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
CH - Svizzera 6
EU - Europa 6
GT - Guatemala 6
HN - Honduras 6
NP - Nepal 6
PT - Portogallo 6
SA - Arabia Saudita 6
HR - Croazia 5
QA - Qatar 5
SV - El Salvador 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
DM - Dominica 4
HU - Ungheria 4
KG - Kirghizistan 4
NG - Nigeria 4
PA - Panama 4
SN - Senegal 4
TW - Taiwan 4
GY - Guiana 3
LB - Libano 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
Totale 47.257
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.465
Wilmington 8.705
Houston 7.496
Singapore 1.393
Fairfield 1.120
Ashburn 1.034
San Jose 879
Ann Arbor 869
Chandler 617
Hong Kong 604
Seattle 475
Cambridge 394
Jacksonville 378
Dublin 361
Beijing 339
Medford 267
Santa Clara 263
Council Bluffs 258
New York 257
The Dalles 218
Dearborn 211
Rome 197
Los Angeles 173
Dallas 172
Ho Chi Minh City 155
Tokyo 149
Lawrence 128
Moscow 124
Buffalo 112
Hanoi 102
Colorado Springs 94
Lauterbourg 91
Zhengzhou 78
São Paulo 66
San Diego 65
Mülheim 64
Milan 63
Denver 47
Menlo Park 45
Munich 45
Chicago 40
Montreal 36
London 35
Corona 34
Brooklyn 29
Toronto 29
Phoenix 27
Boardman 26
Helsinki 26
Nuremberg 26
Atlanta 25
Norwalk 25
Frankfurt am Main 24
Redondo Beach 24
Bologna 23
Orem 23
University Park 23
Warsaw 22
Mexico City 20
Falls Church 19
Johannesburg 19
Naples 19
Brussels 18
Shanghai 18
Amsterdam 17
Chennai 17
Nanjing 17
North Bergen 17
Belo Horizonte 16
Hefei 16
Kraków 16
Mountain View 16
Rio de Janeiro 16
Verona 16
Vienna 16
Washington 16
Da Nang 15
Haiphong 15
Kingston 15
Miami 14
Poplar 14
Stockholm 14
Boston 13
Manchester 13
Redwood City 13
San Francisco 13
Turin 13
Brasília 12
Columbus 12
Kunming 12
Managua 12
Salt Lake City 12
Baghdad 11
Mumbai 11
Queens 11
Seoul 11
Dhaka 10
Jakarta 10
Palo Alto 10
San José 10
Totale 38.675
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 651
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 523
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 509
Acute foetal distress and umbilical cord blood banking 508
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 495
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 494
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 485
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 483
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 483
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 481
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 476
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 469
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 468
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 467
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 465
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 464
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 456
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 454
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 454
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 453
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 452
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 450
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 450
Management of hematological malignancies in patients affected by renal failure 448
Cutaneous involvement in multiple myeloma and bortezomib 445
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 445
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 444
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 443
Pure erythroid leukemia in advanced breast cancer. 442
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 438
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 438
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 437
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 437
Evaluation of biological features of cord blood units collected with different methods after cesarean section 435
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 433
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 430
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 430
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 428
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 428
Cold autoimmune hemolytic anemia resolved by rituximab 427
Bortezomib-related colon mucositis in a multiple myeloma patient 427
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 426
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 424
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 423
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 420
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 419
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 419
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 419
Home care management of patients affected by hematologic malignancies: A review 417
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 416
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 412
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 411
null 410
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 410
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 407
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 407
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 406
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 405
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 404
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 404
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 402
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 400
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 398
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 396
Opioids in pain management of blood-related malignancies 394
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 391
Sleep complaints in hospitalized Italian patients with hematological malignancies 390
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 385
null 385
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 385
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 384
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 381
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 380
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 373
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 373
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 372
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 371
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 369
Stem cell mobilization after coronary artery bypass grafting. 369
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 365
Pain management in multiple myeloma. 343
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 341
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 338
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 324
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 311
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 302
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 302
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 240
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 224
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 221
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 209
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 209
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 198
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 194
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 189
Bone marrow aspiration and biopsy-related pain management 186
Management of pregnant chronic myeloid leukemia patients 184
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 184
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 182
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 175
Totale 39.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 0 0 52 45 113 75 76 70 102 79 377
2022/20231.951 183 144 60 184 124 368 153 91 142 344 117 41
2023/2024916 97 30 79 41 115 217 31 49 25 24 42 166
2024/20253.775 115 895 417 219 137 180 353 142 377 389 280 271
2025/20266.514 547 421 835 529 625 229 823 663 783 559 288 212
2026/20272.084 279 348 1.154 303 0 0 0 0 0 0 0 0
Totale 47.791